LifeSaver
From 2010, SafePoint will pioneer a new campaign called LifeSaver. It will involve inviting all global AD syringe manufacturers to include a new LifeSaver symbol on all ISO standard syringes and packaging. LifeSaver represents the procedure given by a health worker and received by a patient, and can be simply adopted, free of charge by any organisation. The logo is distinctive and easily recognized, and will act as a unique guarantee of a safe injection.

Africa
A key focus area for Safepoint for 2011 is the planning, execution and measurement of a new campaign in Africa. Taking the lessons learnt from the experience in India, and then adapting the framework to suit the different audience and their preferred media, Marc and his team will initially focus on Swaziland, Tanzania, Nigeria and Ghana. Mobile phones and music will be the main communications channels planned to be exploited given the preference of audio rather than visual media by the public at large. Crown sourcing and reporting will also ensure that the public and healthcare profession will be encouraged to ask and use the correct products.

UN Resolution
Marc is currently working to secure a single, global UN resolution that covers both the immunisation and the curative markets. This will have the never-seen-before benefit of providing a universally recognised agreement, an established framework, and a timeline for compliance by all governments with the flexibility to work in all countries. Meetings with various UN Ambassadors are planned across 2012/13.

Cost Saving
Moving away from the people and human suffering stories, Marc believes strongly that an equally hard-hitting message linked to potential cost savings and the bottom line provides a compelling argument when presenting the case for AD syringes to governments, politicians, medial trusts and hospital staff. Hospitals where Safepoint have been working have been telling us that for every $1 they spend on AD syringes they can expect, typically, to save $280. If an injection is given safely then there is no risk of further infection and therefore there no additional costs linked to further treatment. Staff are happier and valuable bed space is kept free.

India
SafePoint is incredibly proud to have single-handedly rolled out one of the largest global health campaigns ever, reaching an audience of over 500 million people. This unprecedented awareness activity which kicked off in November 2008 in India included 14 press calls attended by 200 newspapers, nationwide radio broadcasts and short film screenings on television and in cinemas, and featured the moving story of Sachin, a little boy who contracted HIV through a re-used syringe. As a direct result of this campaign, the Indian Health Ministry made it mandatory for all government health facilities to use AD syringes from the 30th April 2009, and are set to introduce similar legislation for the private sector from April 2011. To ensure continuing momentum and build on the messages from the previous activity, another campaign will run in individual states in India from April 2012, based this time around undercover footage showing shocking, current syringe re-use in hospitals.